Michael F. Santillo
Papers
1
Total Citations
49
H-Index
1
About
Dr. Michael F. Santillo is a leading figure in the evolution of in vitro toxicology, pioneering the integration of high-throughput screening (HTS) to revolutionize chemical safety assessment. His work directly confronts the limitations of traditional animal models—which are costly, slow, and often poor predictors of human response—by championing faster, more predictive human-relevant methods. His landmark 2023 paper, "High-Throughput Screening to Advance In Vitro Toxicology," has already garnered 49 citations, underscoring its immediate impact on the field. In this work, Santillo systematically outlines how HTS can address the critical bottleneck of evaluating thousands of environmental chemicals and drug candidates, shifting the paradigm from reactive animal testing to proactive, mechanism-based hazard identification. His contributions are foundational to the "Toxicity Testing in the 21st Century" movement, providing a clear roadmap for regulators and industry. By demonstrating how to efficiently prioritize compounds for deeper investigation, Santillo is not only accelerating drug development but also reducing reliance on animal testing, making chemical safety evaluation both more ethical and more scientifically robust.
Research Focus
Key Achievements
Top Papers
- 1